|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Net sales | |||||
| Net sales | |||||
| Total net sales | |||||
| Other revenues | |||||
| Other revenues | |||||
| Total other revenues | |||||
| Total revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Acquired IPR&D | |||||
| Selling, general and administrative | |||||
| Impairment of goodwill | |||||
| Litigation settlements and other contingencies, net | |||||
| Total operating expenses | |||||
| Earnings (loss) from operations | |||||
| Interest expense | |||||
| Other expense (income), net | |||||
| Earnings (loss) before income taxes | |||||
| Income tax (benefit) provision | |||||
| Net (loss) earnings | |||||
| (Loss) earnings per share attributable to Viatris Inc. shareholders | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...